Genezen Laboratories Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
270
- Latest Deal Type
-
Debt - Acquisition
- Financing Rounds
-
6
- Investments
-
1
Genezen Laboratories General Information
Description
Provider of cell and gene therapy ContracProvider of cell and gene therapy on a contract development and manufacturing basis focused on early-phase process development, vector production and analytical testing services. The company specializes in offering support to the gene and cell therapy manufacturing market by providing early-phase process development, GMP vector production and analytical testing services.
Contact Information
Website
www.genezen.comCorporate Office
- 9900 Westpoint Drive
- Suite 128
- Indianapolis, IN 46256
- United States
Corporate Office
- 9900 Westpoint Drive
- Suite 128
- Indianapolis, IN 46256
- United States
Genezen Laboratories Timeline
Genezen Laboratories Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Genezen Laboratories Comparisons
Industry
Financing
Details
Genezen Laboratories Competitors (6)
One of Genezen Laboratories’s 6 competitors is ProBio (Drug Discovery), a Venture Capital-Backed company based in Nanjing, China.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| ProBio (Drug Discovery) | Venture Capital-Backed | Nanjing, China | ||||
| Cytovance Biologics | Formerly PE-Backed | Oklahoma City, OK | ||||
| Vector Biomed | Venture Capital-Backed | Gaithersburg, MD | ||||
| Batavia Biosciences | Corporate Backed or Acquired | Leiden, Netherlands | ||||
| Bend Bioscience (Formerly CoreRx) | Private Equity-Backed | Clearwater, FL |
Genezen Laboratories Signals
Genezen Laboratories Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Genezen Laboratories Investments (1)
Genezen Laboratories’s most recent deal was a Buyout/LBO with uniQure (Commercial Gene Therapy Manufacturing Operations) for . The deal was made on 23-Jul-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| uniQure (Commercial Gene Therapy Manufacturing Operations) | 23-Jul-2024 | Buyout/LBO | Other Devices and Supplies |
Genezen Laboratories FAQs
-
When was Genezen Laboratories founded?
Genezen Laboratories was founded in 2014.
-
Where is Genezen Laboratories headquartered?
Genezen Laboratories is headquartered in Indianapolis, IN.
-
What is the size of Genezen Laboratories?
Genezen Laboratories has 270 total employees.
-
What industry is Genezen Laboratories in?
Genezen Laboratories’s primary industry is Biotechnology.
-
Is Genezen Laboratories a private or public company?
Genezen Laboratories is a Private company.
-
What is Genezen Laboratories’s current revenue?
The current revenue for Genezen Laboratories is .
-
How much funding has Genezen Laboratories raised over time?
Genezen Laboratories has raised $46M.
-
Who are Genezen Laboratories’s investors?
Ampersand Capital Partners has invested in Genezen Laboratories.
-
Who are Genezen Laboratories’s competitors?
ProBio (Drug Discovery), Cytovance Biologics, Vector Biomed, Batavia Biosciences, and Bend Bioscience (Formerly CoreRx) are some of the 6 competitors of Genezen Laboratories.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process